Primary study · included by 1 review
Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
Brizel 2000 · Brizel D M, Wasserman T H, Henke M, et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2000
Included by
The review does not say which of its outcomes this study informs.
1 including review in total.